trial · primary record
Pelabresib
Primary Myelofibrosis (PMF)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 460 |
| Primary completion | 2030-12-27 |
| Primary endpoint | Number of Participants with Splenic Response (SVR35) by Central Radiology Reads at Week 24 in participants with baseline total symptom score (TSS) ≥ 25 |
| Registry ID | NCT07357727 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:23.901Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07357727
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.